Product NDC: | 44087-1150 |
Proprietary Name: | Ovidrel |
Non Proprietary Name: | choriogonadotropin alfa |
Active Ingredient(s): | 250 ug/.5mL & nbsp; choriogonadotropin alfa |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44087-1150 |
Labeler Name: | EMD Serono, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021149 |
Marketing Category: | NDA |
Start Marketing Date: | 20031006 |
Package NDC: | 44087-1150-1 |
Package Description: | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS |
NDC Code | 44087-1150-1 |
Proprietary Name | Ovidrel |
Package Description | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) > .5 mL in 1 SYRINGE, GLASS |
Product NDC | 44087-1150 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | choriogonadotropin alfa |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20031006 |
Marketing Category Name | NDA |
Labeler Name | EMD Serono, Inc. |
Substance Name | CHORIOGONADOTROPIN ALFA |
Strength Number | 250 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] |